The Nonclinical Safety Profile of GalNAc-conjugated RNAi Therapeutics in Subacute Studies

Short interfering RNAs (siRNAs) and antisense oligonucleotides (ASOs) are the most clinically advanced oligonucleotide-based platforms. A number of N-acetylgalactosamine (GalNAc)-conjugated siRNAs (GalNAc-siRNAs), also referred to as RNA interference (RNAi) therapeutics, are currently in various sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Janas, Maja M., Harbison, Carole E., Perry, Victoria K., Carito, Brenda, Sutherland, Jessica E., Vaishnaw, Akshay K., Keirstead, Natalie D., Warner, Garvin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249674/
https://www.ncbi.nlm.nih.gov/pubmed/30139307
http://dx.doi.org/10.1177/0192623318792537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6249674/
https://www.ncbi.nlm.nih.gov/pubmed/30139307
http://dx.doi.org/10.1177/0192623318792537

Ejemplares similares